Icares Medicus (Taiwan) Insiders
| 6612 Stock | TWD 116.50 1.50 1.27% |
Icares Medicus employs about 14 people. The company is managed by 14 executives with a total tenure of roughly 76 years, averaging almost 5.0 years of service per executive, having 1.0 employees per reported executive. Recap of Icares Medicus' management performance can provide insight into the venture performance.
| IhHoung Loh Chairman Chairman of the Board, Group Chief Executive Officer |
Icares |
Icares Medicus Management Team Effectiveness
The company has return on total asset (ROA) of 0.0835 % which means that it generated a profit of $0.0835 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1317 %, meaning that it generated $0.1317 on every $100 dollars invested by stockholders. Icares Medicus' management efficiency ratios could be used to measure how well Icares Medicus manages its routine affairs as well as how well it operates its assets and liabilities.Icares Medicus Workforce Comparison
Icares Medicus is rated fourth in number of employees category among its peers. The total workforce of Medical Instruments & Supplies industry is presently estimated at about 130. Icares Medicus retains roughly 14.0 in number of employees claiming about 11% of all equities under Medical Instruments & Supplies industry.
The company has Profit Margin (PM) of 0.27 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.28 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.28. Icares Medicus Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Icares Medicus Price Series Summation is a cross summation of Icares Medicus price series and its benchmark/peer.
Icares Medicus Notable Stakeholders
An Icares Medicus stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Icares Medicus often face trade-offs trying to please all of them. Icares Medicus' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Icares Medicus' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| IhHoung Loh | Chairman of the Board, Group Chief Executive Officer | Profile | |
| TanLi Chen | Group Chief Financial Officer, Head of Finance & Accounting | Profile | |
| Danli Chen | Group Chief Financial Officer, Head of Finance & Accounting | Profile | |
| YingZong Yan | Director | Profile | |
| Jerry Tseng | Vice Chairman of the Board, Group Chief Research & Development Officer | Profile | |
| Kaiyuan Tan | Independent Director | Profile | |
| JhihYing Guo | Independent Director | Profile | |
| William Lee | General Manager, Director | Profile | |
| Robert Cummings | General Manager-Subsidiary | Profile | |
| Hongxun Ding | Independent Director | Profile | |
| WenChu Tseng | Vice Chairman of the Board, Group Chief Research & Development Officer | Profile | |
| ChunMing Lin | Deputy General Manager-Engineering | Profile | |
| Zhiying Guo | Independent Director | Profile | |
| Carl Cummings | Pres Subsidiary | Profile |
About Icares Medicus Management Performance
The success or failure of an entity such as Icares Medicus often depends on how effective the management is. Icares Medicus management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Icares management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Icares management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company was founded in 2011 and is based in Zhubei, Taiwan. ICARES MEDICUS is traded on Taiwan OTC Exchange in Taiwan.
Please note, the imprecision that can be found in Icares Medicus' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Icares Medicus. Check Icares Medicus' Beneish M Score to see the likelihood of Icares Medicus' management manipulating its earnings.
Icares Medicus Workforce Analysis
Traditionally, organizations such as Icares Medicus use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Icares Medicus within its industry.Icares Medicus Manpower Efficiency
Return on Icares Medicus Manpower
| Revenue Per Employee | 28.1M | |
| Revenue Per Executive | 28.1M | |
| Net Income Per Employee | 4.2M | |
| Net Income Per Executive | 4.2M |
Additional Tools for Icares Stock Analysis
When running Icares Medicus' price analysis, check to measure Icares Medicus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icares Medicus is operating at the current time. Most of Icares Medicus' value examination focuses on studying past and present price action to predict the probability of Icares Medicus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icares Medicus' price. Additionally, you may evaluate how the addition of Icares Medicus to your portfolios can decrease your overall portfolio volatility.